Colorectal Cancer Clinical Trials

A look at the following clinical trial: Cytokine Changes After Colorectal Cancer Resection

A look at the following clinical trial: Sentinel Concept in Early Stage Cervical Cancer

A look at the following clinical trial: Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer or Polyposis Syndrome or Who Are at High Risk of Developing Hereditary Colorectal Cancer

A look at the following clinical trial: Trial of Aspirin and Arginine Restriction in Colorectal Cancer

A look at the following clinical trial: Tools for Improving Colorectal Cancer Screening Rates: Multimedia Versus Print

A look at the following clinical trial: Colorectal Cancer Screening in Average-Risk Population: Immunochemical Fecal Occult Blood Testing Versus Colonoscopy

A look at the following clinical trial: MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC)

Provides information to potential participants on the following clinical trial: Study of Pegfilgrastim Administered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab and Either FOLFOX or FOLFIRI

Provides information to potential participants on the following clinical trial: A Phase I/II Study of Gleevec® Combined With Panitumumab (Vectibix®) in Patients Prescreened for C-kit/PDGFr Activated Pathways Using a Proteomic Based Assay

Provides information to potential participants on the following clinical trial: A Randomized, Multicenter, Phase 2 Study to Compare the Efficacy of Panitumumab in Combination With mFOLFOX6 to the Efficacy of Bevacizumab in Combination With mFOLFOX6 in Patients With Previously Untreated, KRAS Wild-Type, Unresectable, Metastatic Colorectal Cancer